Carla van Herpen
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies 3
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 5
- Pancreatic and Hepatic Oncology Research 3
- Surgery top 5%
-
- Lung Cancer Treatments and Mutations 6
- Renal cell carcinoma treatment 5
- Cancer Research top 10%
-
- Renal and related cancers 5
- PI3K/AKT/mTOR signaling in cancer 3
- Melanoma and MAPK Pathways 3
- Co-authors
- Thierry GorliaJacques BernierJean-Louis LefèbvreDidier CupissolJohn S. StewartH. KienzerM. DegardinS. Jelić
- Cited by
- OtorhinolaryngologyOncologySurgery
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Carla van Herpen
28 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Otorhinolaryngology 979
- Oncology 834
- Surgery 864
- Pulmonary and Respiratory Medicine 606
- Cancer Research 162
Countries citing papers authored by Carla van Herpen
This map shows the geographic impact of Carla van Herpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla van Herpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla van Herpen more than expected).
Fields of papers citing papers by Carla van Herpen
This network shows the impact of papers produced by Carla van Herpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla van Herpen. The network helps show where Carla van Herpen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carla van Herpen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 2 | |
| 4 | 2019 | 29 | |
| 5 | 2018 | 2 | |
| 6 | 2018 | 24 | |
| 7 | 2017 | 94 | |
| 8 | 2016 | 47 | |
| 9 | 2016 | 30 | |
| 10 | 2015 | 45 | |
| 11 | 2015 | 1 | |
| 12 | 2015 | 25 | |
| 13 | 2014 | 15 | |
| 14 | 2013 | 8 | |
| 15 | 2012 | 8 | |
| 16 | 2012 | 2 | |
| 17 | 2012 | 40 | |
| 18 | Phase I clinical study of the feasibility of pretargeted radioimmunotherapy (PT-RAIT) in patients with colorectal cancer (CRC): First results | 2011 | 6 |
| 19 | 2009 | 4 | |
| 20 | A Phase III randomized parallel-group study of gefitinib (IRESSA) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck | 2007 | 18 |
About Carla van Herpen
Carla van Herpen is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Renal cell carcinoma treatment (5 papers), Renal and related cancers (5 papers), Colorectal Cancer Treatments and Studies (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Melanoma and MAPK Pathways (3 papers) and Head and Neck Cancer Studies (3 papers). The work is most often cited by research in Otorhinolaryngology (979 citations), Oncology (834 citations) and Surgery (864 citations). Carla van Herpen has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Thierry Gorlia, Jacques Bernier, Jean-Louis Lefèbvre, Didier Cupissol, John S. Stewart, H. Kienzer, M. Degardin, S. Jelić, Daniëlle Van den Weyngaert and Jan B. Vermorken. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.